ZyVersa Therapeutics

$4.4872

-$0.3728 (-7.67%)

на 23:00 17 мая 2024

+167.43%

Потенциал акции через год

Smart Score

Новости по акциям ZyVersa Therapeutics (ZVSA)

ZyVersa Therapeutics, Inc. Announces Reverse Stock Split and Increase in Authorized Shares of Common Stock
Yahoo Finance · 5 месяцев назад Бычья
Promising Prospects of ZyVersa’s VAR 200 and IC 100 Drive ‘Buy’ Rating: An Analyst Recommendation Report
TipRanks News · 6 месяцев назад Нейтральная
ZyVersa Therapeutics Reports Third Quarter 2023 Corporate Update and Financial Results
Yahoo Finance · 6 месяцев назад Нейтральная
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.16%
Investing.com · 6 месяцев назад Нейтральная
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.16%
Investing.com · 6 месяцев назад Нейтральная
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.16%
Investing.com · 6 месяцев назад Нейтральная
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
InvestorPlace · 6 месяцев назад Нейтральная
ZyVersa Therapeutics Announces Article Published in Peer-Reviewed Biomedical Journal Demonstrating That NLRP3 Inflammasome Inhibition Attenuates Inflammatory Bowel Disease Symptoms in Animal Model
Yahoo Finance · 6 месяцев назад Нейтральная
ZyVersa Therapeutics Announces Article in Peer-Reviewed Journal, Ecotoxicology and Environmental Safety, Linking Air Pollution with Development and Progression of Chronic Kidney Disease That Can Be Attenuated by Inhibiting Inflammasome NLRP3 Activation
Yahoo Finance · 6 месяцев назад Нейтральная
ZyVersa Therapeutics Announces Publication in Molecular Neurobiology Reinforcing Data Demonstrating That Inflammasome ASC Inhibitor IC 100 Attenuates the Inflammatory Response Causing Neuronal Damage in Multiple Sclerosis Model, Potentially Providing Neuroprotection
Yahoo Finance · 6 месяцев назад Нейтральная
ZyVersa Therapeutics Announces Research Published in the Peer-Reviewed Journal Diabetes Reinforcing IC 100’s Rationale for Inhibiting ASC to Attenuate Damaging Inflammation Associated with Serious Conditions Such as Obesity-related Heart Disease
Yahoo Finance · 6 месяцев назад Нейтральная
ZyVersa Therapeutics Announces a Publication in the Peer-Reviewed Journal, Aging, Linking Inflammasome NLRP3 Activation with Age-Related Structural Changes in the Kidney and Reduced Kidney Function
Yahoo Finance · 7 месяцев назад Нейтральная
ZyVersa Therapeutics Announces Peer-Reviewed Publication in Nature Reviews Nephrology Substantiating VAR 200’s Rationale for Mediating Transport of Cholesterol and Lipids Out of Kidney Cells to Attenuate Progression of Kidney Disease
Yahoo Finance · 7 месяцев назад Нейтральная
ZyVersa Therapeutics Announces New Peer-Reviewed Publication Reinforcing the Rationale for Inhibiting ASC Specks with IC 100 to Attenuate Spread of Inflammation into Surrounding Tissues
Yahoo Finance · 7 месяцев назад Нейтральная
ZyVersa Therapeutics' CEO, Stephen C. Glover to Participate in Panel at the BioFlorida Conference Discussing Inflammation and its Impact on Numerous Diseases
Yahoo Finance · 7 месяцев назад Нейтральная
ZyVersa Therapeutics Announces Research Published in The Journal of Clinical Investigation Reinforcing IC 100’s Rationale for Inhibiting ASC Specks to Attenuate Spread of Inflammation into Surrounding Tissues
Yahoo Finance · 7 месяцев назад Нейтральная
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.20%
Investing.com · 8 месяцев назад Нейтральная
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.20%
Investing.com · 8 месяцев назад Нейтральная
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.20%
Investing.com · 8 месяцев назад Нейтральная
ZyVersa Therapeutics Announces Research Published in Frontiers in Immunology Reinforcing IC 100’s Rationale for Inhibiting Multiple Inflammasomes to Control Inflammation in Various Inflammatory Diseases
Yahoo Finance · 8 месяцев назад Нейтральная

Что вы думаете об акции
ZVSA ZyVersa Therapeutics?

Поделиться мнением

Проанализируйте акцию ZyVersa Therapeutics
по ключевым показателям

Прогнозы

Рекомендации и консенсус аналитиков с высоким доходом

Хедж-фонды

Официальная отчетность по сделкам 1 хедж-фонда

Инсайдеры

Сделки инсайдеров и инсайдерский сигнал

Дивиденды

Исторические данные и прогнозы по выплатам

ZyVersa Therapeutics

Новости по акциям ZyVersa Therapeutics (ZVSA)

Что вы думаете об акции ZVSA ZyVersa Therapeutics?

Проанализируйте акцию ZyVersa Therapeutics по ключевым показателям

Что вы думаете об акции
ZVSA ZyVersa Therapeutics?

Проанализируйте акцию ZyVersa Therapeutics
по ключевым показателям